Authors
Latest:
FDA Approves Nonopioid Pain Medication in Novel Class for Treatment of Acute PainThe new approval is the first nonopioid option for moderate to severe acute pain in adults.
Latest:
FDA: Nerivio Cleared for Migraine PreventionNerivio received clearance in January 2021 for use in acute migraine.
Latest:
Asembia Does a Great Job Bringing Professionals Together, Experts Say | Asembia 2025The Summit provides a rare opportunity for professionals to dive deep into emerging healthcare technologies and treatment models.
Latest:
Q&A: How Pharmacists Can Help Patients with COPD, Inhaler Misuse | ASHP MidyearDrug Topics met with Lourdes Cross, PharmD, BCACP, CDCES, to discuss pharmacists’ role in managing patients’ chronic obstructive pulmonary disease.
Latest:
New Drug Approvals in PediatricsThis past year has seen several important new drug approvals and labeling updates for children. Here is what you should know.
Latest:
Wildfires Have Significant Impacts on Respiratory HealthThere were more fires in the span of a 13-year period from 2005 to 2018 than in the previous 2 decades.
Latest:
In Depth Perspectives: Psychedelic Medicine, Scope Creep, And MoreCheck out these top featured stories from Drug Topics in April 2024.
Latest:
Q&A: Strategic Vaccine Management Can Drive Pharmacy Success | AAP 2025A conversation with Greg Mitchell, owner of United Drug Superstore in Hatch, New Mexico, at AAP 2025.
Latest:
Review of FDA Approvals for Pediatric Obesity ManagementGLP-1 receptor agonists, used to manage diabetes, are now being used for obesity in children and adolescents.
Latest:
Racial Discrimination in Cancer Care Setting Impacts Black Patients Long-TermBlack patients reported associating negative emotions with experiences of racial discrimination long after the experience concluded, raising concerns about long-term health outcomes.
Latest:
Abrocitinib for Atopic DermatitisThe drug’s approval was based on the results of 3 clinical trials.
Latest:
Q&A: Pharmacist Prescribed Contraception Can Mitigate Barriers to CareA conversation with Ginger Lemay, PharmD, Jeffrey Bratberg, PharmD, and Audrey Whalen, PharmD.
Latest:
Don’t Get Caught Up With a HIPAA ViolationSometimes, breaches in information are the result of a simple mistake. How can those be avoided?
Latest:
Review of FDA Approvals for Pediatric Obesity ManagementGLP-1 receptor agonists, used to manage diabetes, are now being used for obesity in children and adolescents.
Latest:
Q&A: Challenges Health Systems May Face When Integrating BiosimilarsA conversation with Chelsee Jensen, PharmD, BCPS, director of formulary management at the Mayo Clinic.
Latest:
How Rare Cannabinoids Are Disrupting the Pharmaceutical IndustryBy 2029, the global market for cannabinoid-based pharmaceuticals will reach $50 billion.
Latest:
FDA Issues EUA for First Oral Antiviral Pill for COVID-19The pill, Paxlovid, showed an 88% decrease in hospitalization and death for those taking it 5 days after experiencing COVID-19 symptoms.
Latest:
NDA for Investigational Schizophrenia Treatment Submitted to FDAThe NDA was submitted for investigational muscarinic antipsychotic, KarXT (xanomeline-trospium), which functions as a dual M1/M4 muscarinic acetylcholine receptor agonist within the central nervous system.
Latest:
How LucyRx is Changing the Traditional PBM ModelLucyRx is empowering pharmacists and impacting patients’ health outcomes with its business model unlike other market-leading pharmacy benefit managers.
Latest:
Q&A: What AI Is, How It’s Helping Pharmacies with Compliance | NCPDP 2025Stanley V. Campbell, Jr., CEO of EagleForce Associates, Inc., and Yi Deng, PhD, Senior Vice President of Engineering at EagleForce, discuss the basics of AI and how it’s assisting with compliance.
Latest:
Review: Harmful Excipients for Pediatric PatientsEvidence suggests some pharmaceutical excipients in medications may have adverse effects on pediatric patients. Here’s what you should know.
Latest:
Pharmacy Technicians Provide Patient Assistance With Oral OncolyticsPharmacy technicians can provide a great amount of value for patients navigating the financial toxicity of cancer treatment.
Latest:
Where PBM Reform is Headed in 2025, Beyond | NCPDP 2025Attorneys from The Phoenix Law Group joined Drug Topics at NCPDP 2025 to discuss the current state of pharmacy benefit manager reform and where it may end up in the near future.
Latest:
Blood-Based Test Demonstrates High Sensitivity for Colorectal CancerA blood-based cell-free DNA (cfDNA) test was able to find patients at increased risk of colorectal cancer (CRC), advanced neoplasia, and advanced precancerous lesions.
Latest:
Pharmacists Help Patients Manage Chronic PainChronic pain is associated with a significant financial burden, with an estimated cost placed at $650 billion annually in the US.
Latest:
Protecting Our Most Vulnerable Through VaccinationFor more than 70 years, vaccination has been a public health strategy for disease mitigation. Even in populations often considered “vulnerable”—children and pregnant women—vaccination is strongly recommended and commonly embraced.
